PROCTER & GAMBLE SELECTS EVOTEC AS PROVIDER OF PHARMACEUTICAL DISCOVERY SERVICES

Evotec AG and Procter & Gamble Pharmaceuticals, Inc. (P&GP), a subsidiary of The Procter & Gamble Company , today announced that they have entered into agreements whereby Evotec will provide pharmaceutical discovery and chemical development services to P&GP. Under the terms of the agreements, P&GP will access a wide range of discovery and preclinical expertise offered by Evotec, ranging from assay development, screening, medicinal and computational chemistry to scale-up and pharmaceutical manufacture.

PharmaLive (http://www.medadnews.com/News/Index.cfm?articleid=258719)